Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 3 years ago

Possible Interaction: Clozapine and Glycine

supplement:

Glycine

Research Papers that Mention the Interaction

Interestingly, the therapeutic efficacy of glycine was more consistent among patients that were not co-administered clozapine suggesting that clozapine modulates glycine levels in brain.
Schizophrenia Research  •  2004  |  View Paper
Results with D-cycloserine suggest that clozapine may enhance glycine modulatory site occupancy.
Current drug targets. CNS and neurological disorders  •  2002  |  View Paper
We also found that plasma glycine levels and the glycine/l-serine ratio were significantly increased following clozapine treatment in the patients, and the glycine/l-serine ratio was significantly higher in the patients after clozapine treatment than in the controls.
Neuroscience Letters  •  2014  |  View Paper
While glycine improves positive and total symptoms as an adjuvant to non-clozapine antipsychotics, it worsens them when added to clozapine.
CNS drugs  •  2011  |  View Paper
One of the most effective therapeutics for the treatment of substance abuse in schizophrenic people is clozapine, and clozapine may act at the glycine modulatory site to enhance NMDA receptor function.
Neurotoxicity Research  •  2009  |  View Paper
However, these drugs have not shown clinical efficacy when added to clozapine, suggesting that the interactions of clozapine and the glycine site potentiators may be different from those of other antipsychotic drugs and the potentiators.
European Archives of Psychiatry and Clinical Neuroscience  •  2007  |  View Paper
Clozapine inhibited transport of both glycine and MeAIB, but not other amino acids, at concentrations associated with preferential clinical response (0.5–1 μg/ml).
Molecular Psychiatry  •  2005  |  View Paper
Glycine and D-cycloserine have been used in augmentation trials and have exhibited some differences when combined with clozapine versus conventional neuroleptics.
CNS Spectrums  •  2001  |  View Paper